Have Mpox Deaths Exceeded 1,900 in Africa Since 2024?

Synopsis
Key Takeaways
- Mpox deaths have exceeded 1,900 since the start of 2024 in Africa.
- 27 countries are affected by the outbreak.
- Confirmed cases have increased significantly compared to last year.
- A recent decline in cases offers hope for controlling the outbreak.
- Increased testing coverage is essential in fighting mpox.
Addis Ababa, Aug 9 (NationPress) The number of fatalities due to Africa's persistent mpox outbreak has now exceeded 1,900 since the beginning of 2024, according to the Africa Centres for Disease Control and Prevention (Africa CDC).
In an online press briefing, Ngashi Ngongo, the chief of staff and head of the Executive Office at Africa CDC, reported that 27 African nations affected by mpox have collectively documented 174,597 cases and 1,922 related deaths since the start of last year.
“A comparison of the data from last year to this year reveals that, in 2025, we have already recorded 94,300 cases, representing 117 percent of last year's figures. For confirmed cases, we have 29,084 this year compared to 19,713 last year,” Ngongo explained.
Nevertheless, he pointed out that the continent has witnessed a consistent decrease in both confirmed and suspected cases in recent weeks, particularly when compared to the peak in May. The expansion of testing coverage was noted as a positive development in combating the disease, as reported by Xinhua news agency.
Mpox, previously known as monkeypox, was first identified in laboratory monkeys in 1958. This rare viral infection is typically transmitted through body fluids, respiratory droplets, and contaminated materials. The illness often leads to symptoms such as fever, rash, and swollen lymph nodes.
The Africa CDC designated the outbreak a public health emergency of continental significance in August 2024. Subsequently, the World Health Organization classified it as a public health emergency of international concern.
Mpox usually spreads between individuals mainly through close contact with an infected person, including household members. This close contact can involve skin-to-skin, mouth-to-mouth, or mouth-to-skin interactions, and can also occur through face-to-face conversations, which may emit infectious respiratory particles.
Signs and symptoms of mpox typically manifest within a week but can arise anywhere from 1 to 21 days post-exposure. Symptoms generally persist for 2 to 4 weeks, but may extend longer in individuals with compromised immune systems.